1.
Bonita R, Beaglehole R, Kjellström T, World Health Organization, Ebooks Corporation Limited. Basic Epidemiology. 2nd edition. World Health Organization; 2006. https://ebookcentral.proquest.com/lib/gla/detail.action?docID=284799
2.
Rose G. Strategy of prevention : lessons from cardiovascular disease. BMJ. 1981;282(6279):1847-1851. doi:10.1136/bmj.282.6279.1847
3.
Hart J. Measurement of omission. BMJ. 1982;284(6330):1686-1689. doi:10.1136/bmj.284.6330.1686
4.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet. 2012;380(9836):37-43. doi:10.1016/S0140-6736(12)60240-2
5.
Ezzati M, Obermeyer Z, Tzoulaki I, Mayosi BM, Elliott P, Leon DA. Contributions of risk factors and medical care to cardiovascular mortality trends. Nature Reviews Cardiology. 2015;12(9):508-530. doi:10.1038/nrcardio.2015.82
6.
Richards H, Reid M, Watt G. Socio-economic variations in responses to chest pain : a qualitative study. BMJ. 2002;324(7349):1308-1310. doi:10.1136/bmj.324.7349.1308
7.
Jackson R, Wells S, Rodgers A. Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes. BMJ. 2008;337(aug28 2):a1371-a1371. doi:10.1136/bmj.a1371
8.
Capewell S. Will screening individuals at high risk of cardiovascular events deliver large benefits? No. BMJ. 2008;337(aug28 2):a1395-a1395. doi:10.1136/bmj.a1395
9.
Capewell S, Graham H. Will Cardiovascular Disease Prevention Widen Health Inequalities? PLoS Medicine. 2010;7(8). doi:10.1371/journal.pmed.1000320
10.
Reckless JPD. Primary prevention of cardiovascular disease. BMJ. 2011;342(jan25 4):d201-d201. doi:10.1136/bmj.d201
11.
Hingorani AD, Hemingway H. How should we balance individual and population benefits of statins for preventing cardiovascular disease? BMJ. 2010;342(jan26 1):c6244-c6244. doi:10.1136/bmj.c6244
12.
Khunti K, Walker N, Sattar N, Davies M. Unanswered questions over NHS health checks. BMJ. 2010;342(jan26 1):c6312-c6312. doi:10.1136/bmj.c6312
13.
O’Donnell CA, Mackenzie M, Reid M, et al. Delivering a national programme of anticipatory care in primary care: a qualitative study. British Journal of General Practice. 2012;62(597):288-296. doi:10.3399/bjgp12X636137
14.
Linardakis M, Smpokos E, Papadaki A, Komininos I, Tzanakis N, Philalithis A. Prevalence of multiple behavioral risk factor for chronic diseases in adults aged 50+, from eleven European countries – the SHARE study (2004). 57 (3):168-172. https://ezproxy.lib.gla.ac.uk/login?url=https://www.sciencedirect.com/science/article/pii/S0091743513001539
15.
Prochazka AV, Caverly T. General Health Checks in Adults for Reducing Morbidity and Mortality From Disease. JAMA Internal Medicine. 2013;173(5). doi:10.1001/jamainternmed.2013.3187
16.
Artac M, Dalton A, Majeed A, Car J, Millett C. Effectiveness of a national cardiovascular disease risk assessment program (NHS Health Check): Results after one year. 2013;57 (2):129-134. https://ezproxy.lib.gla.ac.uk/login?url=https://www.sciencedirect.com/science/article/pii/S0091743513001473
17.
World Health Organization pages on Cardiovascular Disease. http://www.who.int/cardiovascular_diseases/en/
18.
WHO Factsheet No 317 on Cardiovascular Diseases (CVDs) – updated January 2015. http://www.who.int/mediacentre/factsheets/fs317/en/
19.
WHO Global Atlas on CVD Prevention and Control. http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/
20.
WHO Global Status Report on Noncommunicable Diseases 2014. http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1
21.
Cleland J, Dargie H, Hardman S, McDonagh T, Mitchell P. National heart failure audit. April 2012-March 2013. Published online 2013. http://www.wales.nhs.uk/sitesplus/documents/862/National%20Heart%20Failure%20Audit%20April%202012-March2013.pdf#:~:text=6%20National%20Heart%20Failure%20Audit%20April%202012-March%202013,the%202011%2F12%20cohort.%20This%20improvement%20reflects%20better%20treatment
22.
Acute heart failure: diagnosis and management (NICE guidelines [CG187]). https://www.nice.org.uk/guidance/cg187
23.
Chronic heart failure in adults: management (NICE guidelines [CG108]). http://www.nice.org.uk/guidance/cg108
24.
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2016;37(27):2129-2200. doi:10.1093/eurheartj/ehw128
25.
McAlister FA, Stewart S, Ferrua S, McMurray JJJV. Multidisciplinary strategies for the management of heart failure patients at high risk for admission. Journal of the American College of Cardiology. 2004;44(4):810-819. doi:10.1016/j.jacc.2004.05.055
26.
Sochalski J, Jaarsma T, Krumholz HM, et al. What Works In Chronic Care Management: The Case Of Heart Failure. Health Affairs. 2009;28(1):179-189. doi:10.1377/hlthaff.28.1.179
27.
McMurray JJV, Packer M, Desai AS, et al. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure. New England Journal of Medicine. 2014;371(11):993-1004. doi:10.1056/NEJMoa1409077
28.
Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137-e161. doi:10.1161/CIR.0000000000000509
29.
Cleland J. The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis. European Heart Journal. 2003;24(5):442-463. doi:10.1016/S0195-668X(02)00823-0
30.
SIGN 147: Management of chronic heart failure. A national clinical guideline. Published online 2016. http://www.sign.ac.uk/assets/sign147.pdf
31.
Ezekowitz JA, O’Meara E, McDonald MA, et al. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. Canadian Journal of Cardiology. 2017;33(11):1342-1433. doi:10.1016/j.cjca.2017.08.022
32.
Baron-Franco B, McLean G, Mair FS, Roger VL, Guthrie B, Mercer SW. Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care. British Journal of General Practice. 2017;67(658):e314-e320. doi:10.3399/bjgp17X690533
33.
Royal College of Physicians of Edinburgh Consensus Statement on Atrial Fibrillation. Published online 2012. https://www.rcpe.ac.uk/sites/default/files/files/final_statement.pdf
34.
National clinical guidelines centre. Atrial fibrillation: The management of atrial fibrillation. Published online 2014. https://www.nice.org.uk/guidance/cg180
35.
European society of cardiology. Atrial Fibrillation 2016 (Management of) ESC Clinical Practice Guidelines. Published 2016. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Atrial-Fibrillation-Management
36.
Heidbuchel H, Verhamme P, Alings M, et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2015;17(10):1467-1507. doi:10.1093/europace/euv309
37.
Jani BD, Nicholl BI, McQueenie R, et al. Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. EP Europace. Published online 2 November 2017. doi:10.1093/europace/eux322
38.
Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). European Heart Journal. 2009;30(21):2631-2671. doi:10.1093/eurheartj/ehp298
39.
National Institute for Health and Care Excellence (NICE). Transient loss of consciousness ('blackouts’) management in adults and young people. https://www.nice.org.uk/guidance/cg109
40.
Brignole M, Alboni P, Benditt DG, et al. Guidelines on management (diagnosis and treatment) of syncope – Update 2004. European Heart Journal. 2004;25(22):2054-2072. doi:10.1016/j.ehj.2004.09.004
41.
Kabat H, Anderson JP. Acute Arrest of Cerebral Circulation in Man. Archives of Neurology & Psychiatry. 1943;50(5):510-528. doi:10.1001/archneurpsyc.1943.02290230022002
42.
Determining driver fitness in Canada. https://www.transportation.alberta.ca/content/docType45/Production/CCMTADriverMedicalStandardsAugust2013.pdf
43.
Scottish Intercollegiate Guidelines Network (SIGN). Cardiac arrhythmias in coronary heart disease. Published online 2018. https://www.sign.ac.uk/assets/sign152.pdf
44.
CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. The Lancet. 2015;385(9985):2383-2391. doi:10.1016/S0140-6736(15)60291-4
45.
Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease. New England Journal of Medicine. 2015;372(14):1291-1300. doi:10.1056/NEJMoa1415516
46.
European Society of Cardiology. Stable Coronary Artery Disease (Management of) ESC Clinical Practice Guidelines. European Heart Journal. Published 2013. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Stable-Coronary-Artery-Disease-Management-of
47.
SIGN 96 Scottish Intercollegiate Guidelines Network. management of stable angina. http://www.sign.ac.uk/pdf/sign96.pdf
48.
Angina - NICE CKS. https://cks.nice.org.uk/angina
49.
Scottish Intercollegiate Guidelines Network (SIGN). Management of stable angina. Published online 2018. https://www.sign.ac.uk/sign-151-stable-angina
50.
Gan Y, Gong Y, Tong X, et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2014;14(1). doi:10.1186/s12888-014-0371-z
51.
Thombs BD, Bass EB, Ford DE, et al. Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine. 2006;21(1):30-38. doi:10.1111/j.1525-1497.2005.00269.x
52.
Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations: A Scientific Statement From the American Heart Association. Circulation. 2014;129(12):1350-1369. doi:10.1161/CIR.0000000000000019
53.
Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. General Hospital Psychiatry. 2011;33(3):203-216. doi:10.1016/j.genhosppsych.2011.02.007
54.
Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. European Heart Journal. 2014;35(21):1365-1372. doi:10.1093/eurheartj/eht462
55.
Meijer A, Zuidersma M, de Jonge P. Depression as a non-causal variable risk marker in coronary heart disease. BMC Medicine. 2013;11(1). doi:10.1186/1741-7015-11-130
56.
Thombs BD, Roseman M, Coyne JC, et al. Does Evidence Support the American Heart Association’s Recommendation to Screen Patients for Depression in Cardiovascular Care? An Updated Systematic Review. PLoS ONE. 2013;8(1). doi:10.1371/journal.pone.0052654
57.
Whooley MA, P de J, E V, et al. Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease. JAMA. 2008;300(20). doi:10.1001/jama.2008.711
58.
Poole L, Dickens C, Steptoe A. The puzzle of depression and acute coronary syndrome: Reviewing the role of acute inflammation. Journal of Psychosomatic Research. 2011;71(2):61-68. doi:10.1016/j.jpsychores.2010.12.009
59.
Harris P, Sommargren C, Stein P, Fung G, Drew B. Heart rate variability measurement and clinical depression in acute coronary syndrome patients: narrative review of recent literature. Neuropsychiatric Disease and Treatment. Published online July 2014. doi:10.2147/NDT.S57523
60.
R von K. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? Acta Psychiatr Scand. 2004;110. doi:10.1111/j.1600-0447.2004.00308.x
61.
Jokinen J, Nordström P. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. Journal of Affective Disorders. 2009;116(1-2):88-92. doi:10.1016/j.jad.2008.10.025
62.
Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 1996. doi:10.1002/14651858.CD008012.pub3
63.
Tully PJ, Baumeister H. Collaborative care for comorbid depression and coronary heart disease: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2015;5(12). doi:10.1136/bmjopen-2015-009128
64.
McMurray JJV, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2012;33(14):1787-1847. doi:10.1093/eurheartj/ehs104
65.
Jaarsma T, Beattie JM, Ryder M, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2009;11(5):433-443. doi:10.1093/eurjhf/hfp041
66.
End of life care in heart failure. A framework for implementation. Published online 2014. http://www.nhsiq.nhs.uk/media/2574509/end-of-life-care-in-heart-failure-framework-for-implementation.pdf
67.
Living and dying well: a national action plan for palliative care and end of life care in Scotland. Published online 2008. http://www.palliativecarescotland.org.uk/content/publications/living-and-dying-well.pdf
68.
Living and dying with advanced heart failure: a palliative care approach. Published online 2008. http://www.palliativecarescotland.org.uk/content/publications/HF-final-document.pdf
69.
Hogg KJ, Jenkins SMM. Prognostication or identification of palliative needs in advanced heart failure: where should the focus lie? Heart. 2012;98(7):523-524. doi:10.1136/heartjnl-2012-301753
70.
Johnson M, Beattie J, Hogg K, Watson MS. Heart Failure: From Advanced Disease to Bereavement. Vol Oxford specialist handbooks in end of life care. Oxford University Press; 2012.
71.
Browne S, Macdonald S, May CR, Macleod U, Mair FS. Patient, Carer and Professional Perspectives on Barriers and Facilitators to Quality Care in Advanced Heart Failure. PLoS ONE. 2014;9(3). doi:10.1371/journal.pone.0093288
72.
Pettit SJ, Browne S, Hogg KJ, et al. ICDs in end-stage heart failure. BMJ Supportive & Palliative Care. 2012;2(2):94-97. doi:10.1136/bmjspcare-2011-000176
73.
Fang JC, Ewald GA, Allen LA, et al. Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines Committee. Journal of Cardiac Failure. 2015;21(6):519-534. doi:10.1016/j.cardfail.2015.04.013
74.
Cowie MR, Bax J, Bruining N, et al. e-Health: a position statement of the European Society of Cardiology. European Heart Journal. 2016;37(1):63-66. doi:10.1093/eurheartj/ehv416
75.
Widmer RJ, Collins NM, Collins CS, West CP, Lerman LO, Lerman A. Digital Health Interventions for the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis. Mayo Clinic Proceedings. 2015;90(4):469-480. https://ezproxy.lib.gla.ac.uk/login?url=https://link.galegroup.com/apps/doc/A411614975/AONE?u=glasuni&sid=AONE&xid=0e272c31
76.
Inglis SC, Clark RA, McAlister FA, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database of Systematic Reviews. Published online 1 September 1996. doi:10.1002/14651858.CD007228.pub2
77.
Frederix I, Hansen D, Coninx K, et al. Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation Program With Text Messaging Support for Cardiac Patients: Randomized Controlled Trial. Journal of Medical Internet Research. 2015;17(7). doi:10.2196/jmir.4799
78.
E-Health Strategy 2011-2017. http://www.scotland.gov.uk/Publications/2011/09/09103110/0
79.
Murray E, Burns J, May C, et al. Why is it difficult to implement e-health initiatives? A qualitative study. Implementation Science. 2011;6(1). doi:10.1186/1748-5908-6-6
80.
Mair FS, May C, O’Donnell C, Finch T, Sullivan F, Murray E. Factors that promote or inhibit the implementation of e-health systems: an explanatory systematic review. Bulletin of the World Health Organization. 2012;90(5):357-364. doi:10.2471/BLT.11.099424
81.
Burke LE, Ma J, Azar KMJ, et al. Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention. Circulation. 2015;132(12):1157-1213. doi:10.1161/CIR.0000000000000232
82.
O’Connor S, Hanlon P, O’Donnell CA, Garcia S, Glanville J, Mair FS. Understanding factors affecting patient and public engagement and recruitment to digital health interventions: a systematic review of qualitative studies. BMC Medical Informatics and Decision Making. 2016;16(1). doi:10.1186/s12911-016-0359-3
83.
Lennon MR, Bouamrane MM, Devlin AM, et al. Readiness for Delivering Digital Health at Scale: Lessons From a Longitudinal Qualitative Evaluation of a National Digital Health Innovation Program in the United Kingdom. Journal of Medical Internet Research. 2017;19(2). doi:10.2196/jmir.6900
84.
Mair FS, May CR. Thinking about the burden of treatment. BMJ. 2014;349(nov10 4):g6680-g6680. doi:10.1136/bmj.g6680
85.
May C, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ. 2009;339(aug11 2):b2803-b2803. doi:10.1136/bmj.b2803
86.
Abu Dabrh AM, Gallacher K, Boehmer KR, I.G. H, F.S. M. Minimally disruptive medicine: the evidence and conceptual progress supporting a new era of healthcare. Journal of the Royal College of Physicians of Edinburgh. 2015;45(2):114-117. http://www.rcpe.ac.uk/sites/default/files/mair.pdf
87.
Shippee ND, Allen SV, Leppin AL, May CR, Montori VM. Attaining minimally disruptive medicine: context, challenges and a roadmap for implementation. Journal of the Royal College of Physicians of Edinburgh. 2015;45(2):118-122. https://www.rcpe.ac.uk/sites/default/files/shippee.pdf
88.
Gallacher K, May CR, Montori VM, Mair FS. Understanding Patients’ Experiences of Treatment Burden in Chronic Heart Failure Using Normalization Process Theory. The Annals of Family Medicine. 2011;9(3):235-243. doi:10.1370/afm.1249
89.
Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. Journal of Clinical Epidemiology. 2012;65(10):1041-1051. doi:10.1016/j.jclinepi.2012.05.005
90.
May CR, Eton DT, Boehmer K, et al. Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health Services Research. 2014;14(1). doi:10.1186/1472-6963-14-281
91.
Jani B, Blane D, Browne S, et al. Identifying treatment burden as an important concept for end of life care in those with advanced heart failure. Current Opinion in Supportive and Palliative Care. 2013;7(1):3-7. doi:10.1097/SPC.0b013e32835c071f
92.
Gallacher K, Morrison D, Jani B, et al. Uncovering Treatment Burden as a Key Concept for Stroke Care: A Systematic Review of Qualitative Research. PLoS Medicine. 2013;10(6). doi:10.1371/journal.pmed.1001473
